Global Metastatic Prostate Cancer Treatment Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Report ID: GIR2301010010 | Category: Pharma & Healthcare | Pages: 102 | Format: PDF | Published Date: February 14,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3480.00 Multi User-$5220.00

Report Description
View Table of Contents

Report Summary

Metastatic prostate cancer is a type of prostate cancer which spreads to the other parts of body such as bones or lymph nodes.
According to our (Global Info Research) latest study, the global Metastatic Prostate Cancer Treatment market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Metastatic Prostate Cancer Treatment market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Metastatic Prostate Cancer Treatment market size and forecasts, in consumption value ($ Million), 2018-2029
Global Metastatic Prostate Cancer Treatment market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Metastatic Prostate Cancer Treatment market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Metastatic Prostate Cancer Treatment market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Metastatic Prostate Cancer Treatment
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Metastatic Prostate Cancer Treatment market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AB Science, BeiGene, eFFECTOR Therapeutics, Immunomedics(Gilead Sciences, Inc.) and Myovant Biosciences, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Metastatic Prostate Cancer Treatment market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
    Mono
    Combination
    Mono/Combination
Market segment by Application
    Hospital
    Drug Store
    Online Pharmacy
Market segment by players, this report covers
    AB Science
    BeiGene
    eFFECTOR Therapeutics
    Immunomedics(Gilead Sciences, Inc.)
    Myovant Biosciences
    SeleXel
    Zenith Epigenetics Ltd.
    VasGene Therapeutics, Inc.
    Telix Pharmaceuticals
    Arvinas Inc.
    Amgen
    Genentech
Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Metastatic Prostate Cancer Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Metastatic Prostate Cancer Treatment, with revenue, gross margin and global market share of Metastatic Prostate Cancer Treatment from 2018 to 2023.
Chapter 3, the Metastatic Prostate Cancer Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Metastatic Prostate Cancer Treatment market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Metastatic Prostate Cancer Treatment.
Chapter 13, to describe Metastatic Prostate Cancer Treatment research findings and conclusion.

1 Market Overview
    1.1 Product Overview and Scope of Metastatic Prostate Cancer Treatment
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Metastatic Prostate Cancer Treatment by Type
        1.3.1 Overview: Global Metastatic Prostate Cancer Treatment Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global Metastatic Prostate Cancer Treatment Consumption Value Market Share by Type in 2022
        1.3.3 Mono
        1.3.4 Combination
        1.3.5 Mono/Combination
    1.4 Global Metastatic Prostate Cancer Treatment Market by Application
        1.4.1 Overview: Global Metastatic Prostate Cancer Treatment Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Hospital
        1.4.3 Drug Store
        1.4.4 Online Pharmacy
    1.5 Global Metastatic Prostate Cancer Treatment Market Size & Forecast
    1.6 Global Metastatic Prostate Cancer Treatment Market Size and Forecast by Region
        1.6.1 Global Metastatic Prostate Cancer Treatment Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global Metastatic Prostate Cancer Treatment Market Size by Region, (2018-2029)
        1.6.3 North America Metastatic Prostate Cancer Treatment Market Size and Prospect (2018-2029)
        1.6.4 Europe Metastatic Prostate Cancer Treatment Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific Metastatic Prostate Cancer Treatment Market Size and Prospect (2018-2029)
        1.6.6 South America Metastatic Prostate Cancer Treatment Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa Metastatic Prostate Cancer Treatment Market Size and Prospect (2018-2029)
2 Company Profiles
    2.1 AB Science
        2.1.1 AB Science Details
        2.1.2 AB Science Major Business
        2.1.3 AB Science Metastatic Prostate Cancer Treatment Product and Solutions
        2.1.4 AB Science Metastatic Prostate Cancer Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 AB Science Recent Developments and Future Plans
    2.2 BeiGene
        2.2.1 BeiGene Details
        2.2.2 BeiGene Major Business
        2.2.3 BeiGene Metastatic Prostate Cancer Treatment Product and Solutions
        2.2.4 BeiGene Metastatic Prostate Cancer Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 BeiGene Recent Developments and Future Plans
    2.3 eFFECTOR Therapeutics
        2.3.1 eFFECTOR Therapeutics Details
        2.3.2 eFFECTOR Therapeutics Major Business
        2.3.3 eFFECTOR Therapeutics Metastatic Prostate Cancer Treatment Product and Solutions
        2.3.4 eFFECTOR Therapeutics Metastatic Prostate Cancer Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 eFFECTOR Therapeutics Recent Developments and Future Plans
    2.4 Immunomedics(Gilead Sciences, Inc.)
        2.4.1 Immunomedics(Gilead Sciences, Inc.) Details
        2.4.2 Immunomedics(Gilead Sciences, Inc.) Major Business
        2.4.3 Immunomedics(Gilead Sciences, Inc.) Metastatic Prostate Cancer Treatment Product and Solutions
        2.4.4 Immunomedics(Gilead Sciences, Inc.) Metastatic Prostate Cancer Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Immunomedics(Gilead Sciences, Inc.) Recent Developments and Future Plans
    2.5 Myovant Biosciences
        2.5.1 Myovant Biosciences Details
        2.5.2 Myovant Biosciences Major Business
        2.5.3 Myovant Biosciences Metastatic Prostate Cancer Treatment Product and Solutions
        2.5.4 Myovant Biosciences Metastatic Prostate Cancer Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Myovant Biosciences Recent Developments and Future Plans
    2.6 SeleXel
        2.6.1 SeleXel Details
        2.6.2 SeleXel Major Business
        2.6.3 SeleXel Metastatic Prostate Cancer Treatment Product and Solutions
        2.6.4 SeleXel Metastatic Prostate Cancer Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 SeleXel Recent Developments and Future Plans
    2.7 Zenith Epigenetics Ltd.
        2.7.1 Zenith Epigenetics Ltd. Details
        2.7.2 Zenith Epigenetics Ltd. Major Business
        2.7.3 Zenith Epigenetics Ltd. Metastatic Prostate Cancer Treatment Product and Solutions
        2.7.4 Zenith Epigenetics Ltd. Metastatic Prostate Cancer Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Zenith Epigenetics Ltd. Recent Developments and Future Plans
    2.8 VasGene Therapeutics, Inc.
        2.8.1 VasGene Therapeutics, Inc. Details
        2.8.2 VasGene Therapeutics, Inc. Major Business
        2.8.3 VasGene Therapeutics, Inc. Metastatic Prostate Cancer Treatment Product and Solutions
        2.8.4 VasGene Therapeutics, Inc. Metastatic Prostate Cancer Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 VasGene Therapeutics, Inc. Recent Developments and Future Plans
    2.9 Telix Pharmaceuticals
        2.9.1 Telix Pharmaceuticals Details
        2.9.2 Telix Pharmaceuticals Major Business
        2.9.3 Telix Pharmaceuticals Metastatic Prostate Cancer Treatment Product and Solutions
        2.9.4 Telix Pharmaceuticals Metastatic Prostate Cancer Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Telix Pharmaceuticals Recent Developments and Future Plans
    2.10 Arvinas Inc. 
        2.10.1 Arvinas Inc. Details
        2.10.2 Arvinas Inc. Major Business
        2.10.3 Arvinas Inc. Metastatic Prostate Cancer Treatment Product and Solutions
        2.10.4 Arvinas Inc. Metastatic Prostate Cancer Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Arvinas Inc. Recent Developments and Future Plans
    2.11 Amgen
        2.11.1 Amgen Details
        2.11.2 Amgen Major Business
        2.11.3 Amgen Metastatic Prostate Cancer Treatment Product and Solutions
        2.11.4 Amgen Metastatic Prostate Cancer Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 Amgen Recent Developments and Future Plans
    2.12 Genentech
        2.12.1 Genentech Details
        2.12.2 Genentech Major Business
        2.12.3 Genentech Metastatic Prostate Cancer Treatment Product and Solutions
        2.12.4 Genentech Metastatic Prostate Cancer Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 Genentech Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 Global Metastatic Prostate Cancer Treatment Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of Metastatic Prostate Cancer Treatment by Company Revenue
        3.2.2 Top 3 Metastatic Prostate Cancer Treatment Players Market Share in 2022
        3.2.3 Top 6 Metastatic Prostate Cancer Treatment Players Market Share in 2022
    3.3 Metastatic Prostate Cancer Treatment Market: Overall Company Footprint Analysis
        3.3.1 Metastatic Prostate Cancer Treatment Market: Region Footprint
        3.3.2 Metastatic Prostate Cancer Treatment Market: Company Product Type Footprint
        3.3.3 Metastatic Prostate Cancer Treatment Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
    4.1 Global Metastatic Prostate Cancer Treatment Consumption Value and Market Share by Type (2018-2023)
    4.2 Global Metastatic Prostate Cancer Treatment Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
    5.1 Global Metastatic Prostate Cancer Treatment Consumption Value Market Share by Application (2018-2023)
    5.2 Global Metastatic Prostate Cancer Treatment Market Forecast by Application (2024-2029)
6 North America
    6.1 North America Metastatic Prostate Cancer Treatment Consumption Value by Type (2018-2029)
    6.2 North America Metastatic Prostate Cancer Treatment Consumption Value by Application (2018-2029)
    6.3 North America Metastatic Prostate Cancer Treatment Market Size by Country
        6.3.1 North America Metastatic Prostate Cancer Treatment Consumption Value by Country (2018-2029)
        6.3.2 United States Metastatic Prostate Cancer Treatment Market Size and Forecast (2018-2029)
        6.3.3 Canada Metastatic Prostate Cancer Treatment Market Size and Forecast (2018-2029)
        6.3.4 Mexico Metastatic Prostate Cancer Treatment Market Size and Forecast (2018-2029)
7 Europe
    7.1 Europe Metastatic Prostate Cancer Treatment Consumption Value by Type (2018-2029)
    7.2 Europe Metastatic Prostate Cancer Treatment Consumption Value by Application (2018-2029)
    7.3 Europe Metastatic Prostate Cancer Treatment Market Size by Country
        7.3.1 Europe Metastatic Prostate Cancer Treatment Consumption Value by Country (2018-2029)
        7.3.2 Germany Metastatic Prostate Cancer Treatment Market Size and Forecast (2018-2029)
        7.3.3 France Metastatic Prostate Cancer Treatment Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom Metastatic Prostate Cancer Treatment Market Size and Forecast (2018-2029)
        7.3.5 Russia Metastatic Prostate Cancer Treatment Market Size and Forecast (2018-2029)
        7.3.6 Italy Metastatic Prostate Cancer Treatment Market Size and Forecast (2018-2029)
8 Asia-Pacific
    8.1 Asia-Pacific Metastatic Prostate Cancer Treatment Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific Metastatic Prostate Cancer Treatment Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Region
        8.3.1 Asia-Pacific Metastatic Prostate Cancer Treatment Consumption Value by Region (2018-2029)
        8.3.2 China Metastatic Prostate Cancer Treatment Market Size and Forecast (2018-2029)
        8.3.3 Japan Metastatic Prostate Cancer Treatment Market Size and Forecast (2018-2029)
        8.3.4 South Korea Metastatic Prostate Cancer Treatment Market Size and Forecast (2018-2029)
        8.3.5 India Metastatic Prostate Cancer Treatment Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia Metastatic Prostate Cancer Treatment Market Size and Forecast (2018-2029)
        8.3.7 Australia Metastatic Prostate Cancer Treatment Market Size and Forecast (2018-2029)
9 South America
    9.1 South America Metastatic Prostate Cancer Treatment Consumption Value by Type (2018-2029)
    9.2 South America Metastatic Prostate Cancer Treatment Consumption Value by Application (2018-2029)
    9.3 South America Metastatic Prostate Cancer Treatment Market Size by Country
        9.3.1 South America Metastatic Prostate Cancer Treatment Consumption Value by Country (2018-2029)
        9.3.2 Brazil Metastatic Prostate Cancer Treatment Market Size and Forecast (2018-2029)
        9.3.3 Argentina Metastatic Prostate Cancer Treatment Market Size and Forecast (2018-2029)
10 Middle East & Africa
    10.1 Middle East & Africa Metastatic Prostate Cancer Treatment Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa Metastatic Prostate Cancer Treatment Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Country
        10.3.1 Middle East & Africa Metastatic Prostate Cancer Treatment Consumption Value by Country (2018-2029)
        10.3.2 Turkey Metastatic Prostate Cancer Treatment Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia Metastatic Prostate Cancer Treatment Market Size and Forecast (2018-2029)
        10.3.4 UAE Metastatic Prostate Cancer Treatment Market Size and Forecast (2018-2029)
11 Market Dynamics
    11.1 Metastatic Prostate Cancer Treatment Market Drivers
    11.2 Metastatic Prostate Cancer Treatment Market Restraints
    11.3 Metastatic Prostate Cancer Treatment Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
    12.1 Metastatic Prostate Cancer Treatment Industry Chain
    12.2 Metastatic Prostate Cancer Treatment Upstream Analysis
    12.3 Metastatic Prostate Cancer Treatment Midstream Analysis
    12.4 Metastatic Prostate Cancer Treatment Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Metastatic Prostate Cancer Treatment Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?